Summary The Asia-Pacific region is home to more than half of the global population and
accounted for 62· 6% of global deaths due to liver diseases in 2015. 54· 3% of global deaths …

Hepatitis B virus (HBV) and hepatitis C virus (HCV) cause 1.3 million deaths annually. To
prevent more than 7 million deaths by 2030, the World Health Organization set goals to …

The global tuberculosis (TB) and child health community has increasingly prioritized the
childhood TB epidemic. In 2013, the childhood TB subgroup developed and published the …

Introduction There are positive aspects regarding the prescribing of fixed dose combinations
(FDCs) versus prescribing the medicines separately. However, these have to be balanced …

Summary Background The World Health Assembly calls for elimination of viral hepatitis as a
public health threat by 2030 (ie,− 90% incidence and− 65% mortality). However, WHO's …

Purpose This study aims to examine the burden of primary liver cancer in 185 countries in
2018. Methods The estimates of incidence, mortality and prevalence of primary liver cancer …

Hepatitis C has a relevant global impact in terms of morbidity, mortality and economic costs,
with more than 70 million people infected worldwide. In the resolution,“Transforming our …

Background Limited treatment data are available for hepatitis C virus (HCV) in sub-Saharan
Africa, especially for genotype 4. Our objective was to establish the safety and efficacy of …

When cost-effective interventions are unaffordable: Integrating cost-effectiveness and
budget impact in priority setting for global health programs | PLOS Medicine Skip to main …

ObjectivesQuality-adjusted life-years (QALYs) and disability-adjusted life-years (DALYs) are
commonly used in cost-effectiveness analysis (CEA) to measure health benefits. We sought …